Assessment of ovarian tumor marker CA-125 during radiotherapy course
| Autor: | Adel Al-Ghanim, Mohammed A. Aliomer, Mohammed Farahna, Mohamed Yousef, Mohamed Elfadil Mohamed |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Radical treatment
Oncology medicine.medical_specialty business.industry medicine.medical_treatment Cancer stage Normal level General Medicine medicine.disease General Biochemistry Genetics and Molecular Biology Radiation therapy Ovarian tumor Immune system Antigen Ovarian cancer Radiation therapy and tumor maker Radioimmuneassay Health Care Sciences and Services Internal medicine medicine Sağlık Bilimleri ve Hizmetleri Ovarian cancer business |
| Zdroj: | Volume: 30, Issue: 2 137-139 Journal of Experimental and Clinical Medicine |
| ISSN: | 1309-4483 1309-5129 |
| Popis: | The antigen secretion by ovarian cancer (CA-125) has been assessed using Radio Immune Assay (RIA) technique among a hundred ovarian cancer patients who received radiotherapy course as radical treatment. The study revealed that, the ovarian cancer commonly associated with the age groups of 30-40 years old taking a percent of 68 relative to other age groups and the antigen CA-125 does not has relation with aging. While the radiotherapy shows it is efficiency in management of ovarian cancer by reducing the antigen CA-125 level from 134 ± 13.3 U/ml to 5.5 ± 2.1 U/ml relative to normal level of CA-125 (35 U/ml). Also there is significant relationship between the cancer stage and the level of antigen CA-125 (R2=0.98). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|